Biopsafe ApS: Financial statements 2022
CVR: 33575505
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 6,081,000 and a net result of DKK 1,447,000 compared with DKK 250,066 the year before. That is a decrease of 19.4% compared with the year before. Equity in the 2022 report amounted to DKK 5,698,000. The solvency ratio was 21.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 6,081,000
- Profit/Loss
- DKK 1,447,000
- Equity
- DKK 5,698,000
- Total Assets
- DKK 26,671,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 6.1 mio. | 1.4 mio. | 5.7 mio. | 2 |
| 2021 | - | 7.5 mio. | 250 t. | 4.3 mio. | 3 |
| 2020 | - | 5.2 mio. | 219 t. | 4 mio. | 3 |
| 2019 | - | 6.3 mio. | 268 t. | 3.8 mio. | 1 |
| 2018 | - | 4.6 mio. | 39 t. | 3.5 mio. | 1 |
Official annual report
Keep an eye on Biopsafe ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biopsafe ApS has published its annual report for 2021. Gross profit came to DKK 7,541,402, and the net result was DKK 250,066.
As of January 24, 2022, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Biopsafe ApS.
As of January 24, 2022, Taastrup 2024 P/S has stepped down as auditor of Biopsafe ApS.
As of January 24, 2022, Søren Kofoed Christensen is registered as director of Biopsafe ApS.
As of January 24, 2022, Ole Jakobsen has stepped down as director of Biopsafe ApS.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.